Adiso Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Adiso Therapeutics is a biotechnology research company based in Concord, Massachusetts, focused on developing medicines for inflammatory diseases. It aims to address limitations of existing therapies, which often fail to halt disease progression or raise safety concerns. The company pursues novel programs, including ADS032, an inhibitor of inflammasomes associated with NLRP1 and NLRP3, and ADS024, a single-strain live biotherapeutic product with a distinctive mechanism. 

Its target market includes patients affected by inflammatory diseases and the clinicians who treat them, seeking therapies with improved efficacy and safety. In October 2023, the company announced the appointment of Robert Lisicki to its board of directors, marking governance expansion.

Sign up for free to view info

Company overview Email format